[Hypolipidemic activity of glycine and its derivatives].
A hypolipidemic action of glycine and its derivatives glycylglycine, clofibrylglycine, clofibrylglycylglycine was studied in intact and hyperlipidemic rats and guinea pigs.
D000818:Animals; D002784:Cholesterol / Q000097:blood* / Q000378:metabolism; D002994:Clofibrate / Q000494:pharmacology / Q000627:therapeutic use; D002995:Clofibric Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D006033:Glycylglycine / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D006168:Guinea Pigs; D006949:Hyperlipidemias / Q000097:blood* / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D007928:Lethal Dose 50; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D051381:Rats; D014280:Triglycerides / Q000097:blood* / Q000378:metabolism
D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D014280:Triglycerides; D006033:Glycylglycine; C041845:clofibrylglycine; D002995:Clofibric Acid; C041846:clofibrylglycylglycine; D002784:Cholesterol; D002994:Clofibrate; D005998:Glycine
Gipolipidemicheskoe deĭstvie glitsina i ego proizvodnykh.